EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jos G. Maessen
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sauren, L. D.C.
Right arrow Articles by Maessen, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sauren, L. D.C.
Right arrow Articles by Maessen, J. G.
Related Collections
Right arrow Cerebral protection
Right arrow Extracorporeal circulation

Eur J Cardiothorac Surg 2007;32:274-280. doi:10.1016/j.ejcts.2007.02.033
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

New ultrasonic radiation reduces cerebral emboli during extracorporeal circulation

Loes D.C. Saurena,*, Mark la Meira, Meindert Palmena, Ervin Severdijaa, Frederik H. van der Veena, Werner H. Messb, Jos G. Maessena

a Cardiovascular Research Institute Maastricht, Department of Cardiothoracic Surgery, Academic Hospital Maastricht, The Netherlands
b Cardiovascular Research Institute Maastricht, Department of Clinical Neurophysiology, Academic Hospital Maastricht, The Netherlands

Received 11 October 2006; received in revised form 15 February 2007; accepted 16 February 2007.

* Corresponding author. Address: Department of Cardiothoracic Surgery, Academic Hospital Maastricht, P. Debyelaan 25, 6229HX Maastricht, The Netherlands. Tel.: +31 43 3875070; fax: +31 43 3875993.

Objective: Cardiac surgery is associated with intraoperative cerebral emboli, which can result in postoperative neurological complications. A new ultrasonic transducer (EmBlockerTM) can be positioned on the ascending aorta and activation of the EmBlockerTM is expected to divert emboli to the descending aorta, thereby decreasing emboli in the cerebral arteries. In this preliminary animal study, safety and efficiency of this technology were examined. Methods: In 14 pigs (±70 kg), a median sternotomy was performed and the EmBlockerTM was positioned on the aorta ascendens at the level of the bifurcation of the aorta and the innominate artery. In one animal temperature measurements were performed. During these measurements, the EmBlockerTM was activated for four periods of 120 s of high power (1.5 W/cm2) and for four periods of 600 s of low power (0.5 W/cm2). In the safety study (n = 6), the EmBlockerTM was activated twice the expected clinical duration (eight periods of 120 s of high power and, subsequently, one period of 20 min of low power). Tissue samples (control and sonicated) were collected after 1 week for histopathological evaluation (aorta, trachea, esophagus, vagus nerves). In the efficiency study (n = 7), extracorporeal circulation was installed. Emboli (air and solid (1200, size 500 µm–750 µm)) were introduced in the proximal ascending aorta and the EmBlockerTM was alternately activated with high power for solid emboli injections and low power for air emboli injections. Transcranial Doppler (TCD) was used to analyse middle cerebral artery blood flow for occurrence of embolic signals, which were manually counted offline. Results: Histopathology revealed no difference between control and sonicated tissue. There is a rise in temperature during EmBlockerTM activation, but in all measured tissues it was within limits; less then 42 °C for 2 min in the aorta wall directly under the EmBlockerTM. Use of the EmBlockerTM significantly reduced emboli in the cerebral arteries in an animal model; air emboli with 65% (left) and 69% (right) and solid emboli with 49% (left) and 50% (right). Conclusions: The new ultrasound technology can safely be applied and is capable of reducing emboli in the cerebral arteries during extracorporeal circulation. Use of the EmBlockerTM in cardiac surgery bears the potential to lower the risk of postoperative neurological complications. Clinical feasibility studies are in progress.

Key Words: Cerebral emboli • Transcranial Doppler • Cardiac surgery • Ultrasound







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.